1. Home
  2. PERI vs IMRX Comparison

PERI vs IMRX Comparison

Compare PERI & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perion Network Ltd.

PERI

Perion Network Ltd.

SELL

Current Price

$8.72

Market Cap

346.5M

Sector

Technology

ML Signal

SELL

Logo Immuneering Corporation

IMRX

Immuneering Corporation

HOLD

Current Price

$3.62

Market Cap

232.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PERI
IMRX
Founded
1999
2008
Country
Israel
United States
Employees
N/A
57
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
346.5M
232.3M
IPO Year
2005
2021

Fundamental Metrics

Financial Performance
Metric
PERI
IMRX
Price
$8.72
$3.62
Analyst Decision
Buy
Strong Buy
Analyst Count
6
7
Target Price
$13.00
★ $17.17
AVG Volume (30 Days)
237.2K
★ 663.1K
Earning Date
11-11-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 37.75
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$5.75
N/A
Revenue Next Year
$10.33
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$7.63
$3.38
52 Week High
$11.27
$8.48

Technical Indicators

Market Signals
Indicator
PERI
IMRX
Relative Strength Index (RSI) 48.09 35.41
Support Level $8.28 N/A
Resistance Level $9.70 $5.32
Average True Range (ATR) 0.24 0.18
MACD 0.06 -0.02
Stochastic Oscillator 51.91 31.18

Price Performance

Historical Comparison
PERI
IMRX

About PERI Perion Network Ltd.

Perion Network Ltd is a technology company. It offers online advertising and search solutions to brands, agencies, and publishers through desktop, mobile, and social channels. It connects advertisers to consumers across digital advertising channels, including search advertising, social, display, video, digital audio, digital out of home (DOOH), and Connected TV (CTV) advertising. The company earns prime revenue from search advertising and display advertising services. It operates in the business segment of High Impact Advertising solutions. Geographically, the company generates a majority of its revenue from the United States and the rest from other regions.

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Share on Social Networks: